This stabilization amplifies the oncogenic potential of mutant p53, leading to enhanced chemoresistance (e.g., to paclitaxel and cisplatin), sustained DNA damage repair capacity, suppression of mitotic checkpoints, and promotion of tumor cell survival under genotoxic stress. This evidence concerns the gene TP53 and neoplasm.